Visudyne Injection, Powder, Lyophilized, For Solution
Product Images NDC 0187-5600

2 FDA label images from Bausch Health Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Visudyne (NDC 0187-5600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure diagrams of verteporfin, the active ingredient in Visudyne injection. The image shows two structural variants labeled I and II, each with labeled ring systems A, B, C, and D, depicting the molecular configuration of the compound.*
FDA Label Image

Carton (Image 02)

Carton (Image 02)
Packaging label for Visudyne 15 mg injection, powder, lyophilized for solution, indicated for intravenous use. The label shows it is a single-use vial distributed by Bausch + Lomb, a division of Bausch Health US LLC, and manufactured by Alcami Carolinas Corporation. The label includes the active ingredient verteporfin 2 mg per mL of reconstituted solution, storage instructions, and a barcode with NDC 0187-5600-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.